flufenamic acid has been researched along with Innate Inflammatory Response in 31 studies
Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Flufenamic acid and mefenamic acid are efficacious in NLRP3-dependent rodent models of inflammation in air pouch and peritoneum." | 3.83 | Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models. ( Allan, SM; Bagnall, J; Baldwin, AG; Booth, SJ; Brough, D; Daniels, MJ; Eder, C; Fasolino, V; Fischer, N; Freeman, S; Galea, J; Harte, MK; Jackson, J; Koziel, V; Latta, C; Lawrence, CB; Paszek, P; Pillot, T; Rivers-Auty, J; Schilling, T; Spencer, NG; Watremez, W; White, CS; Wong, R; Yu, S, 2016) |
| "Burns are soft tissue injuries that require particular care for wound healing." | 1.51 | Efficiency of Multiparticulate Delivery Systems Loaded with Flufenamic Acid Designed for Burn Wound Healing Applications. ( Albu-Kaya, MG; Costache, M; Danilă, E; Dinescu, S; Ghica, MV; Ignat, SR; Lazar, AD; Marin, MM; Marin, Ș; Udeanu, DI, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (77.42) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (22.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Maccari, R | 1 |
| Ottanà, R | 1 |
| Vivier, D | 1 |
| Bennis, K | 1 |
| Lesage, F | 1 |
| Ducki, S | 1 |
| Spray, DC | 1 |
| Iglesias, R | 1 |
| Shraer, N | 1 |
| Suadicani, SO | 1 |
| Belzer, V | 1 |
| Hanstein, R | 1 |
| Hanani, M | 1 |
| Dinescu, S | 1 |
| Ignat, SR | 1 |
| Lazar, AD | 1 |
| Marin, Ș | 1 |
| Danilă, E | 1 |
| Marin, MM | 1 |
| Udeanu, DI | 1 |
| Ghica, MV | 1 |
| Albu-Kaya, MG | 1 |
| Costache, M | 1 |
| Calder, BW | 1 |
| Matthew Rhett, J | 1 |
| Bainbridge, H | 1 |
| Fann, SA | 1 |
| Gourdie, RG | 1 |
| Yost, MJ | 1 |
| Daniels, MJ | 1 |
| Rivers-Auty, J | 1 |
| Schilling, T | 1 |
| Spencer, NG | 1 |
| Watremez, W | 1 |
| Fasolino, V | 1 |
| Booth, SJ | 1 |
| White, CS | 1 |
| Baldwin, AG | 1 |
| Freeman, S | 1 |
| Wong, R | 1 |
| Latta, C | 1 |
| Yu, S | 1 |
| Jackson, J | 1 |
| Fischer, N | 1 |
| Koziel, V | 1 |
| Pillot, T | 1 |
| Bagnall, J | 1 |
| Allan, SM | 1 |
| Paszek, P | 1 |
| Galea, J | 1 |
| Harte, MK | 1 |
| Eder, C | 1 |
| Lawrence, CB | 1 |
| Brough, D | 1 |
| WINDER, CV | 2 |
| WAX, J | 2 |
| SERRANO, B | 1 |
| JONES, EM | 1 |
| McPHEE, ML | 1 |
| WELFORD, M | 1 |
| Mörsdorf, K | 2 |
| Cornelissen, G | 1 |
| Balestrieri, B | 1 |
| Capasso, L | 1 |
| Masiello, S | 1 |
| Castaldo, S | 1 |
| Capasso, F | 1 |
| Caramanis, C | 1 |
| Varonos, DD | 1 |
| Dell, HD | 1 |
| Fiedler, J | 1 |
| Jacobi, H | 1 |
| Kolle, J | 1 |
| Roubal, Z | 1 |
| Grimová, J | 1 |
| Nĕmecek, O | 1 |
| Cepelák, V | 1 |
| Ito, M | 2 |
| Anspach, K | 1 |
| Perper, RJ | 1 |
| Sanda, M | 1 |
| Chinea, G | 1 |
| Oronsky, AL | 1 |
| Jancsó-Gábor, A | 1 |
| Szolcsányi, J | 1 |
| Mizushima, Y | 1 |
| Tsukada, W | 1 |
| Akimoto, T | 1 |
| Iizuka, Y | 1 |
| Tanaka, K | 1 |
| Bacon, PA | 1 |
| Dieppe, PA | 1 |
| Wawrzyńska-Pagowska, J | 1 |
| Di Perri, T | 1 |
| Auteri, A | 1 |
| Tsurumi, K | 2 |
| Hiramatsu, Y | 2 |
| Nozaki, M | 1 |
| Hayashi, M | 2 |
| Shibuya, T | 2 |
| Yamaguchi, A | 1 |
| Kimura, S | 1 |
| Kaump, DH | 1 |
| Nakanishi, M | 1 |
| Imamura, H | 1 |
| Ikegami, K | 1 |
| Goto, K | 1 |
| Homma, M | 1 |
| Jahn, U | 1 |
| Adrian, RW | 1 |
3 reviews available for flufenamic acid and Innate Inflammatory Response
| Article | Year |
|---|---|
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Struc | 2016 |
[Clinical use of non-steroid anti-inflammatory agents].
Topics: Animals; Anti-Inflammatory Agents; Antigen-Antibody Complex; Arthritis, Rheumatoid; Aspirin; Cell Mi | 1974 |
[Non-steroidal anti-inflammatory drugs for eye diseases].
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Child; Child, Preschool; Enzyme Therapy; Eye Diseases; | 1968 |
1 trial available for flufenamic acid and Innate Inflammatory Response
| Article | Year |
|---|---|
Skin testing in the assessment of antiinflammatory drugs in man.
Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Flufenamic Acid; Histamine; Humans; Hypersensiti | 1972 |
27 other studies available for flufenamic acid and Innate Inflammatory Response
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions.
Topics: Aldehyde Reductase; Aldo-Keto Reductases; Diabetes Complications; Diabetes Mellitus; Enzyme Inhibito | 2015 |
Gap junction mediated signaling between satellite glia and neurons in trigeminal ganglia.
Topics: Animals; Boron Compounds; Carbenoxolone; Cells, Cultured; Disease Models, Animal; Female; Flufenamic | 2019 |
Efficiency of Multiparticulate Delivery Systems Loaded with Flufenamic Acid Designed for Burn Wound Healing Applications.
Topics: Animals; Burns; Capsules; Cell Proliferation; Cell Survival; Cells, Cultured; Collagen; Drug Compoun | 2019 |
Inhibition of connexin 43 hemichannel-mediated ATP release attenuates early inflammation during the foreign body response.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Biotinylation; Calcium; Cells, Cultured; Conne | 2015 |
Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Cells; Cell Death; | 2016 |
Anti-inflammatory and antipyretic properties of N-(alpha,alpha,alpha-trifluoro-m-tolyl) anthranilic acid (CI-440; flufenamic acid).
Topics: Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents; Antipyretics; Body Temperature; Eryt | 1963 |
ANTI-INFLAMMATORY AND ANTIPYRETIC PROPERTIES OF N-(2,6-DICHLORO-M-TOLYL)ANTHRANILIC ACID (CI-583).
Topics: Aminopyrine; Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents; Antipyretics; Aspirin; | 1965 |
[Contribution to the evaluation of anti-inflammatory agents in vitro].
Topics: Animals; Anti-Inflammatory Agents; Cortisone; Esterases; Flufenamic Acid; Indomethacin; Inflammation | 1966 |
[Scopolamine and its pharmacological effects on some experimental inflammation tests].
Topics: Animals; Carrageenan; Cellulose; Dextrans; Edema; Flufenamic Acid; Granuloma; Indomethacin; Inflamma | 1980 |
The influence of acetylsalicylic acid, phenylbutazone, indomethacin, and flufenamic acid on the kinetics of leucocytes during acute inflammation.
Topics: Analgesics; Animals; Aspirin; Cell Movement; Flufenamic Acid; Indomethacin; Inflammation; Kinetics; | 1980 |
[Gas-liquid chromatographic determination of etofenamate/ Determination, method and use in biological material (author's transl)].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, Gas; Flufenamic Acid; Half-Life; H | 1981 |
Effects of nonsteroid anti-inflammatory agents and some dicoumarol derivatives on platelet aggregation, fibrinolysis and stabilization of cell membrane in vitro.
Topics: Anti-Inflammatory Agents; Aspirin; Blood Platelets; Cell Membrane; Chloroquine; Coumarins; Depressio | 1972 |
[Influence of various drugs on the tissue permeability. 6. Effect of anti-inflammatory drugs on quantitative changes in connective tissue components in inflamed tissues of filter paper-implanted rats].
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Aspirin; Barbiturates; Benzyl Compounds; Connective | 1973 |
[Efficacy of different antiphlogistic agents with respect to carrageenan-inflammation, compared with other models of inflammation].
Topics: Adrenocorticotropic Hormone; Aminopyrine; Animals; Anti-Inflammatory Agents; Aspirin; Carrageenan; D | 1971 |
Leukocyte chemotaxis in vivo. II. Analysis of the selective inhibition of neutrophil or mononuclear cell accumulation.
Topics: Animals; Bucladesine; Carrageenan; Chemotaxis; Chloroquine; Chlorpromazine; Chromium Radioisotopes; | 1974 |
Action of rare earth metal complexes on neurogenic as well as on bradykinin-induced inflammation.
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Antivenins; Blood Coagulation; Bradykinin; Catech | 1970 |
A modification of rat adjuvant arthritis for testing antirheumatic drugs.
Topics: Adjuvants, Immunologic; Aminopyrine; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthr | 1972 |
][A new method for screening of analgesics applied to heat induced inflammatory pain].
Topics: Aminopyrine; Analgesics; Animals; Aspirin; Burns; Drug Evaluation, Preclinical; Flufenamic Acid; Hab | 1974 |
[Influence of various drugs on the tissue permeability. 7. Effect of anti-inflammatory drugs on the changes in mucopolysaccharase activity in inflamed tissues of filter paper-implanted rats].
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Aspirin; Dexamethasone; Enzyme Activation; Female; F | 1973 |
[Anti-complement activity in vitro and in vivo of some non-steroid anti-inflammatory drugs].
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Complement Inactivator Proteins; Flufenamic Acid; Hemoly | 1973 |
[Anti-inflammatory action of N-(2,6-dichlorophenyl)-o-aminophenylacetic acid, its sodium salt, N-(2,6-dichlorophenyl)-anthranilic acid and its sodium salt. 1. On acute inflammation].
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Capillary Permeability; Edema; Electrolytes; Eryth | 1973 |
[Anti-inflammatory action of N-(2,6-dichlorophenyl)-o-aminophenylacetic acid, its sodium salt, N-(2,6-dichlorophenyl)-anthranilic acid and its sodium salt. 2. On subacute inflammation].
Topics: Acute Disease; Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Arthritis; Body Weight; Ed | 1973 |
Experimental observations on flufenamic, mefanamic and meclofenamic acids. II. Toxicology in animals.
Topics: Aluminum; Animals; Anti-Inflammatory Agents; Calcium; Colon; Dogs; Edema; Female; Flufenamic Acid; F | 1966 |
Pharmacological investigations of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine.
Topics: Acid Phosphatase; Analgesics; Animals; Anti-Inflammatory Agents; Antibody Formation; Aspirin; Blood | 1970 |
[Clinical evaluation of non-steroid anti-inflammatory drugs].
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Flufenamic Acid; Humans; Indomethacin; Inf | 1968 |
[Pharmacological and toxicological testing of new anti-inflammatory agent azapropazon=3-dimethylamine-7-methyl-1,2-(n-propylmalonyl)-1,2-dihydro-1,2,4-benzotriazine].
Topics: Abnormalities, Drug-Induced; Analgesics; Anesthetics, Local; Animals; Anti-Inflammatory Agents; Bloo | 1969 |